Nanbiosis Committees

Coordination Committee

• Jaume Veciana, Scientific Director of NANBIOSIS; Director of  Molecular Nanosciences and Organic Materials Dpt. (ICMAB-CSIC)  and Coordinator of Platform Programme of CIBER BBN.
• Francisco Miguel Sánchez Margallo; Assistant Director of NANBIOSIS and Scientific Director of JUMISC
• Ramón Martínez Máñez, Scientific Director of CIBER-BBNPI of  the Group of Applied Molecular Chemistry Center of Molecular Recognition and Technological Development of the Polytechnic University of Valencia (UPV-ADM-IQMA) Scientific Director of NANBIOSIS Unit 26
• María Luisa García Martín, Scientific Director of NANBIOSIS Unit 28, PI of the Group Biomedical Magnetic Resonance Laboratory-BIONAND,
• Pablo Laguna, Scientific Director of NANBIOSIS Unit 27, PI of the Biomedical Signal Interpretation and Computational Simulation (BSICoS) group; Scientific Coordinator of  I3A (Aragon Institute of Engineering Research)
• Verónica Crisóstomo, Researcher at the Endoluminal Diagnostic and Therapeutic Unit of the Minimally Invasive Surgery Center Jesús Usón.

Scientific-Technical Advisory Board

• Begoña Castro, Scientific Director of Histocell, Madrid
• Pilar Calvo, Pharmaceutical Development Manager of PHARMAMAR
• Anton Ussi, Operations and Finance Director at EATRIS ERIC, the European Infrastructure for Translational Medicine, Amsterdam, The Netherlands
• Ruth Schmid. Vicepresident SINTEF, Norway
• Jürguen Borlak, Director of Institute for Pharmaco- and Toxicogenomics, Hannover Medical School, Germany
• Stefania Raimondo, Professor at the University of Turin, Italy
• Anna Bigas, Scientific Director o CIBERONC and researcher at IMIM
• Ignacio Santiago Álvarez, Professor of the University of Extremadura / Scientific Director IERA-GC, Badajoz
• Francisco Fernández Avilés, Chair of the Department of Cardiology, University Hospital Gregorio Marañón, Madrid
• Antonio Bernad, Research Professor at Immunology and Oncology Department, National Center for Biotechnology (CNB), Madrid
• Pedro Pesini, Senior Manager, Scientific Affairs en Araclon Biotech-Grifols

Access Committee

• Joan Bausells, Research Professor at the Institute of Microelectronics of Barcelona, CSIC.
• Mª Eugenia Fernández Santos, Director of Advanced Therapy Medicinal Products Production Unit and Regenerative Medicine-GMP facilities of Gregorio Marañón Hospital, Madrid
• Angel Maquieira, Research Professor at the Polytechnic University of Valencia
• Javier García Casado, Associate Professor at the University of Extremadura, Cáceres, Spain
• Jose Maria Perez Pomares, Professor and Director of the Department of Animal Biology at the University of Malaga